Cagrilintide
Long-acting amylin analog with extended half-life for combination weight therapy. Designed for co-formulation with GLP-1 agonists to achieve synergistic appetite suppression and weight reduction.
Our Cagrilintide API (CAS:1415456-99-3) is a long-acting dual amylin/calcitonin receptor agonist peptide, used for R&D of metabolic disorders, weight management and glycemic control, meeting international quality control requirements for scientific research and pharmaceutical R&D. With stable supply, global fast delivery and professional service, we help customers efficiently advance R&D and industrialization.
| Parameter | Specification |
| CAS | 1415456-99-3 |
| Molecular Formula | C₁₉₄H₃₁₇N₅₅O₆₅S |
| Molecular Weight | 4401.08 g/mol |
| Category | GLP-1/Metabolic |
| Purity | ≥99% |
| Status | GMP-compliant, FDA-ready |
| Applications | Obesity, combination weight therapy, amylin receptor research |
| CAS | 1415456-99-3 |
|---|---|
| Applications | Amylin, Diabetes adjunct therapy, obesity management, weight management |
Related products
-
Glucagon HCl
CAS: 16941-32-5Applications: Diabetic Emergency, Glycogenolysis, Hypoglycemia Rescue -
Abarelix
CAS: 183552-38-7Applications: Advanced Prostate Cancer, Hormone-dependent Tumors, Testosterone Suppression -
Exenatide Acetate
CAS: 141732-76-5Applications: GLP-1, obesity management, Type 2 diabetes -
Dulaglutide
CAS: 923950-08-7